Molecular and metabolic changes in neurological manifestations of Post-COVID conditions with special consideration of spectroscopy MR analysis-Reference-Cited by-同舟云学术

Molecular and metabolic changes in neurological manifestations of Post-COVID conditions with special consideration of spectroscopy MR analysis

Published:2023-09-01 Issue:2 Volume:11 Page:60-64
ISSN:2544-3577
Container-title:Medical Journal of Cell Biology
language:en
Short-container-title:

Author:

Iwaszkiewicz Pawel¹,Iwanowski Robert¹,Wozniak Slawomir²

Affiliation:

1. 1 STN (Students Scientific Society) Anatomia-Klinika-Nauka. Department of Human Morphology and Embryology, Division of Anatomy , Wroclaw Medical University , Wroclaw , Poland

2. 2 Department of Human Morphology and Embryology, Division of Anatomy , Wroclaw Medical University , Wroclaw , Poland

Abstract

Abstract Post-COVID conditions (PCC) are conditions that continue or develop after acute COVID-19 infection. This review provides a comprehensive overview of current knowledge on the molecular and metabolic basis of neurological manifestations of PCC, with particular emphasis on Magnetic Resonance Spectroscopy (MRS) analysis. MRS is a technique used to measure the concentrations of different metabolites in tissues within the human body (including central nervous system) and may contribute to a more precise understanding of the pathophysiology of this condition and the development of new therapeutic methods.

Publisher

Walter de Gruyter GmbH

Subject

Cell Biology,Molecular Biology

Link

https://www.sciendo.com/pdf/10.2478/acb-2023-0010

Reference51 articles.

1. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135; DOI:10.1016/j.bbi.2021.12.020.

2. Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39-48; DOI:10.1016/j. euroneuro.2021.03.019.

3. Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Brünink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, Rößler L, Goebel HH, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, Körtvélyessy P, Reinhold D, Siegmund B, Kühl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168-175; DOI:10.1038/s41593-020-00758-5.

4. de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, Kergoat L, Kornobis E, Donati F, Cokelaer T, Hervochon R, Madec Y, Roze E, Salmon D, Bourhy H, Lecuit M, Lledo PM. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 20212;13(596):eabf8396; DOI:10.1126/scitranslmed.abf8396.

5. Aragão MFVV, Leal MC, Cartaxo Filho OQ, Fonseca TM, Valença MM. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol. 2020;41(9):1703-6; DOI:10.3174/ajnr. A6675.